Domenica Karavitaki, Ph.D., serves as Skylark Bio’s Director of Research and Development, where she leads the company’s scientific strategy and execution across preclinical programs. Dr. Karavitaki directs the design and interpretation of preclinical studies, guiding the path toward clinical development. 

With over 30 years of experience in hearing science, Dr. Karavitaki brings deep expertise to Skylark Bio’s research efforts. In addition to overseeing research operations and guiding a team of scientists, Dr. Karavitaki is responsible for delivering an IND for the company’s first indication. 

Dr. Karavitaki earned her Ph.D. from the Harvard-MIT Health Sciences and Technology Program, specializing in Speech and Hearing Biosciences and Technology, and completed postdoctoral research in neurobiology and neuroscience at Harvard Medical School. She holds both Bachelor’s and Master’s degrees in Biomedical Engineering from Boston University.